Connect with us
A breakthrough in weight-loss drug development is on the horizon, thanks to the innovative research led by Associate Professor Christoffer Clemmensen from the Novo Nordisk Foundation...
Recent research reveals that weekly injections of semaglutide medications, such as Ozempic, significantly lower the risk of severe kidney outcomes, major cardiovascular events, and death among...
